Cargando…
Protein and Site Specificity of Fucosylation in Liver-Secreted Glycoproteins
[Image: see text] Chronic liver diseases are a serious health problem worldwide. One of the frequently reported glycan alterations in liver disease is aberrant fucosylation, which was suggested as a marker for noninvasive serologic monitoring. We present a case study that compares site specific glyc...
Autores principales: | Pompach, Petr, Ashline, David J., Brnakova, Zuzana, Benicky, Julius, Sanda, Miloslav, Goldman, Radoslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261953/ https://www.ncbi.nlm.nih.gov/pubmed/25265424 http://dx.doi.org/10.1021/pr5005482 |
Ejemplares similares
-
Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma
of Patients with Liver Disease
por: Benicky, Julius, et al.
Publicado: (2014) -
Analysis of site and structure specific core fucosylation in liver cirrhosis using exoglycosidase-assisted data-independent LC-MS/MS
por: Sanda, Miloslav, et al.
Publicado: (2021) -
Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
por: Sanda, Miloslav, et al.
Publicado: (2016) -
A Rapid LC-MS/MS-PRM Assay for Serologic Quantification of Sialylated O-HPX Glycoforms in Patients with Liver Fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2022) -
A multiplexed microflow LC–MS/MS-PRM assay for serologic quantification of IgG N- and HPX O- glycoforms in liver fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2023)